227 related articles for article (PubMed ID: 14717972)
21. Matrix metalloproteinase-2: A key regulator in coagulation proteases mediated human breast cancer progression through autocrine signaling.
Das K; Prasad R; Ansari SA; Roy A; Mukherjee A; Sen P
Biomed Pharmacother; 2018 Sep; 105():395-406. PubMed ID: 29870887
[TBL] [Abstract][Full Text] [Related]
22. Factor VIIa-induced p44/42 mitogen-activated protein kinase activation requires the proteolytic activity of factor VIIa and is independent of the tissue factor cytoplasmic domain.
Sørensen BB; Freskgård PO; Nielsen LS; Rao LV; Ezban M; Petersen LC
J Biol Chem; 1999 Jul; 274(30):21349-54. PubMed ID: 10409695
[TBL] [Abstract][Full Text] [Related]
23. Factor VIIa-induced interaction with integrin controls the release of tissue factor on extracellular vesicles from endothelial cells.
Rothmeier AS; Versteeg HH; Ruf W
J Thromb Haemost; 2019 Apr; 17(4):627-634. PubMed ID: 30740873
[TBL] [Abstract][Full Text] [Related]
24. Role of protease activated receptor 1 and 2 signaling in hypoxia-induced angiogenesis.
Uusitalo-Jarvinen H; Kurokawa T; Mueller BM; Andrade-Gordon P; Friedlander M; Ruf W
Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1456-62. PubMed ID: 17363687
[TBL] [Abstract][Full Text] [Related]
25. Alteration in endothelial permeability occurs in response to the activation of PAR2 by factor Xa but not directly by the TF-factor VIIa complex.
Benelhaj NE; Maraveyas A; Featherby S; Collier MEW; Johnson MJ; Ettelaie C
Thromb Res; 2019 Mar; 175():13-20. PubMed ID: 30677622
[TBL] [Abstract][Full Text] [Related]
26. Protease-activated receptors-1 and -2 can mediate endothelial barrier protection: role in factor Xa signaling.
Feistritzer C; Lenta R; Riewald M
J Thromb Haemost; 2005 Dec; 3(12):2798-805. PubMed ID: 16359518
[TBL] [Abstract][Full Text] [Related]
27. The tissue factor/factor VIIa/factor Xa complex: a model built by docking and site-directed mutagenesis.
Norledge BV; Petrovan RJ; Ruf W; Olson AJ
Proteins; 2003 Nov; 53(3):640-8. PubMed ID: 14579355
[TBL] [Abstract][Full Text] [Related]
28. Enhanced expression of urokinase receptor induced through the tissue factor-factor VIIa pathway in human pancreatic cancer.
Taniguchi T; Kakkar AK; Tuddenham EG; Williamson RC; Lemoine NR
Cancer Res; 1998 Oct; 58(19):4461-7. PubMed ID: 9766679
[TBL] [Abstract][Full Text] [Related]
29. Activation of β1 integrins and caveolin-1 by TF/FVIIa promotes IGF-1R signaling and cell survival.
Åberg M; Edén D; Siegbahn A
Apoptosis; 2020 Aug; 25(7-8):519-534. PubMed ID: 32458278
[TBL] [Abstract][Full Text] [Related]
30. Coagulation factor VIIa enhances programmed death-ligand 1 expression and its stability in breast cancer cells to promote breast cancer immune evasion.
Paul S; Das K; Ghosh A; Chatterjee A; Bhoumick A; Basu A; Sen P
J Thromb Haemost; 2023 Dec; 21(12):3522-3538. PubMed ID: 37579880
[TBL] [Abstract][Full Text] [Related]
31. The tick-derived inhibitor Ixolaris prevents tissue factor signaling on tumor cells.
Carneiro-Lobo TC; Schaffner F; Disse J; Ostergaard H; Francischetti IM; Monteiro RQ; Ruf W
J Thromb Haemost; 2012 Sep; 10(9):1849-58. PubMed ID: 22823596
[TBL] [Abstract][Full Text] [Related]
32. Role of protease-activated receptor-2 in idiopathic pulmonary fibrosis.
Wygrecka M; Kwapiszewska G; Jablonska E; von Gerlach S; Henneke I; Zakrzewicz D; Guenther A; Preissner KT; Markart P
Am J Respir Crit Care Med; 2011 Jun; 183(12):1703-14. PubMed ID: 21471103
[TBL] [Abstract][Full Text] [Related]
33. Identification of the integrin-binding site on coagulation factor VIIa required for proangiogenic PAR2 signaling.
Rothmeier AS; Liu E; Chakrabarty S; Disse J; Mueller BM; Østergaard H; Ruf W
Blood; 2018 Feb; 131(6):674-685. PubMed ID: 29246902
[TBL] [Abstract][Full Text] [Related]
34. Nucleic acid sensing promotes inflammatory monocyte migration through biased coagulation factor VIIa signaling.
Zelaya H; Grunz K; Nguyen TS; Habibi A; Witzler C; Reyda S; Gonzalez-Menendez I; Quintanilla-Martinez L; Bosmann M; Weiler H; Ruf W
Blood; 2024 Mar; 143(10):845-857. PubMed ID: 38096370
[TBL] [Abstract][Full Text] [Related]
35. FVIIa prevents the progressive hemorrhaging of a brain contusion by protecting microvessels via formation of the TF-FVIIa-FXa complex.
Yuan Q; Zhang D; Wu S; Yu J; Yu L; Sun Y; Du Z; Li Z; Zhou L; Wu X; Hu J
Neuroscience; 2017 Apr; 348():114-125. PubMed ID: 28223242
[TBL] [Abstract][Full Text] [Related]
36. Cortactin activation by FVIIa/tissue factor and PAR2 promotes endothelial cell migration.
Zhu T; Mancini JA; Sapieha P; Yang C; Joyal JS; Honoré JC; Leduc M; Zaniolo K; Hardy P; Shao Z; Fan L; Hou X; Rivard GE; Chemtob S
Am J Physiol Regul Integr Comp Physiol; 2011 Mar; 300(3):R577-85. PubMed ID: 21160057
[TBL] [Abstract][Full Text] [Related]
37. The epidermal growth factor receptor (EGFR) and proline rich tyrosine kinase 2 (PYK2) are involved in tissue factor dependent factor VIIa signalling in HaCaT cells.
Wiiger MT; Prydz H
Thromb Haemost; 2004 Jul; 92(1):13-22. PubMed ID: 15213840
[TBL] [Abstract][Full Text] [Related]
38. Activation of cancer cell migration and invasion by ectopic synthesis of coagulation factor VII.
Koizume S; Jin MS; Miyagi E; Hirahara F; Nakamura Y; Piao JH; Asai A; Yoshida A; Tsuchiya E; Ruf W; Miyagi Y
Cancer Res; 2006 Oct; 66(19):9453-60. PubMed ID: 17018600
[TBL] [Abstract][Full Text] [Related]
39. Apixaban Suppresses the Release of TF-Positive Microvesicles and Restrains Cancer Cell Proliferation through Directly Inhibiting TF-fVIIa Activity.
Featherby S; Madkhali Y; Maraveyas A; Ettelaie C
Thromb Haemost; 2019 Sep; 119(9):1419-1432. PubMed ID: 31266079
[TBL] [Abstract][Full Text] [Related]
40. Tissue factor cytoplasmic domain stimulates migration by activation of the GTPase Rac1 and the mitogen-activated protein kinase p38.
Ott I; Weigand B; Michl R; Seitz I; Sabbari-Erfani N; Neumann FJ; Schömig A
Circulation; 2005 Jan; 111(3):349-55. PubMed ID: 15642762
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
